Teucrium Corn Fund vs Eli Lilly And Co — how do they compare? Teucrium Corn Fund trades at $19.06 (market cap $125.39M), while Eli Lilly And Co trades at $1,166.23 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 8294.1× Teucrium Corn Fund's market cap, and Eli Lilly And Co pays a 0.59% dividend while Teucrium Corn Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teucrium Corn Fund for 26 Days and Eli Lilly And Co for 93 Days on average.
| CORN | LLY | |
|---|---|---|
Market Cap | $125.39M | $1.04T |
Volume | 271,634 | 3,064,878 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $20.29 | $1.28K |
52-Week Low | $16.46 | $799.57 |
Typical Hold Time | 26 Days | 93 Days |
Enterprise Value | — | $1.09T |
Dividend Yield | — | 0.59% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,188.72, up 2.7% today, reflecting strong momentum driven by robust earnings beats and bullish technical signals. The stock exhibits impressive fundamentals with 2025 revenue of $65.18B and net income of $20.64B, yielding a net margin of 31.66%. Recent news highlights promising pipeline developments in weight-loss drugs, including EloraTZP, which outperformed Zepbound in trials, reinforcing its competitive edge in the obesity and diabetes markets.
Outlook remains positive given analyst consensus of a $1,350 price target and 73% buy ratings, though high valuation multiples (P/E 39.26) and rising debt-to-asset ratios (42.78% in 2024) warrant caution. Key risks include regulatory hurdles and intensifying competition from rivals like Novo Nordisk, but Lilly's innovation pipeline and market leadership position it for sustained growth.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
CORN is a commodity ETF that provides exposure to the price of corn futures. It uses a laddered investment strategy across multiple benchmark contracts to help minimize the impact of contango and roll costs in the agricultural market.
Read more on CORN →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →